[Skip to Content]
[Skip to Content Landing]
Editor's Correspondence
October 25, 1999

Drug-Associated Agranulocytosis: Experience at Strasbourg Teaching Hospital

Author Affiliations

Copyright 1999 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.1999

Arch Intern Med. 1999;159(19):2366-2367. doi:

We read with great interest the study by van der Klauw et al1 of drug-associated agranulocytosis in a Dutch hospital. We agree with their conclusions (the highest risks of drug-induced agranulocytosis occur with thyroid inhibitors, the combination drug sulfamethoxazole-trimethoprim, sulfasalazine, clomipramine hydrochloride, and dipyrone combined with analgesics) and want to give some data from our own experience.2

First Page Preview View Large
First page PDF preview
First page PDF preview